New editorial in the FASEB Journal raises concerns over dietary supplements

As the FDA warns consumers to stop using Hydroxycut products, a new editorial published in the May 2009 issue of The FASEB Journal shows that this FDA warning is not unique. In the editorial, Gerald Weissmann, M.D. Editor-in-Chief of the journal and Research Professor of Medicine and Director of the Biotechnology Study Centre at NYU School of Medicine, examines litigation involving StarCaps dietary supplement weight loss capsules to illustrate regulatory loopholes that make it impossible for the FDA to prevent dangerous substances sold with health claims from reaching the market...

Read the whole article on

More from